Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis

IntroductionThis study examined the role of echocardiographic and cardiac histomorphology parameters in predicting mortality in patients with cardiac AL amyloidosis.MethodsPatients with endomyocardial biopsy-proven cardiac AL amyloidosis treated at MD Anderson Cancer Center between 6/2011 and 6/2020...

Full description

Bibliographic Details
Main Authors: Efstratios Koutroumpakis, Adam Niku, Christopher K. Black, Abdelrahman Ali, Humaira Sadaf, Juhee Song, Nicolas Palaskas, Cezar Iliescu, Jean-Bernard Durand, Syed Wamique Yusuf, Hans C. Lee, L. Maximilian Buja, Anita Deswal, Jose Banchs
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1073804/full
_version_ 1797944966169755648
author Efstratios Koutroumpakis
Adam Niku
Christopher K. Black
Abdelrahman Ali
Humaira Sadaf
Juhee Song
Nicolas Palaskas
Cezar Iliescu
Jean-Bernard Durand
Syed Wamique Yusuf
Hans C. Lee
L. Maximilian Buja
Anita Deswal
Jose Banchs
author_facet Efstratios Koutroumpakis
Adam Niku
Christopher K. Black
Abdelrahman Ali
Humaira Sadaf
Juhee Song
Nicolas Palaskas
Cezar Iliescu
Jean-Bernard Durand
Syed Wamique Yusuf
Hans C. Lee
L. Maximilian Buja
Anita Deswal
Jose Banchs
author_sort Efstratios Koutroumpakis
collection DOAJ
description IntroductionThis study examined the role of echocardiographic and cardiac histomorphology parameters in predicting mortality in patients with cardiac AL amyloidosis.MethodsPatients with endomyocardial biopsy-proven cardiac AL amyloidosis treated at MD Anderson Cancer Center between 6/2011 and 6/2020 were identified. Stored echocardiographic images and endomyocardial biopsy samples were processed for myocardial strain analysis and a detailed histomorphology characterization.ResultsOf 43 patients; 44% were women and 63% white. Median age was 65 years; 51% underwent stem cell transplantation (SCT). Thirty patients (70%) died during follow up (median follow up: 4.1 years). Lower LA strain (<13.5%) and absence of SCT as a time-varying covariate were significantly associated with increased risk of death in the multivariate cox regression analysis. Higher LV mass and lower RV tricuspid annular plane systolic excursion were associated with increased odds of having ≥5% interstitial amyloid deposition on biopsy in the multivariate logistic regression analysis.ConclusionLower LA strain independently predicted mortality in our cohort, and its performance in the routine assessment of AL amyloidosis may be beneficial. Furthermore, SCT for cardiac AL amyloidosis was associated with improved OS. These findings need to be confirmed by larger studies in the era of contemporary systemic therapies.
first_indexed 2024-04-10T20:47:54Z
format Article
id doaj.art-547885b42a0f45d7b272a60ef3dd8d3d
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-10T20:47:54Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-547885b42a0f45d7b272a60ef3dd8d3d2023-01-24T05:22:57ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-01-01910.3389/fcvm.2022.10738041073804Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosisEfstratios Koutroumpakis0Adam Niku1Christopher K. Black2Abdelrahman Ali3Humaira Sadaf4Juhee Song5Nicolas Palaskas6Cezar Iliescu7Jean-Bernard Durand8Syed Wamique Yusuf9Hans C. Lee10L. Maximilian Buja11Anita Deswal12Jose Banchs13Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pathology and Laboratory Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, United StatesDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pathology and Laboratory Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, United StatesDivision of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Cardiology, University of Colorado School of Medicine, Aurora, CO, United StatesIntroductionThis study examined the role of echocardiographic and cardiac histomorphology parameters in predicting mortality in patients with cardiac AL amyloidosis.MethodsPatients with endomyocardial biopsy-proven cardiac AL amyloidosis treated at MD Anderson Cancer Center between 6/2011 and 6/2020 were identified. Stored echocardiographic images and endomyocardial biopsy samples were processed for myocardial strain analysis and a detailed histomorphology characterization.ResultsOf 43 patients; 44% were women and 63% white. Median age was 65 years; 51% underwent stem cell transplantation (SCT). Thirty patients (70%) died during follow up (median follow up: 4.1 years). Lower LA strain (<13.5%) and absence of SCT as a time-varying covariate were significantly associated with increased risk of death in the multivariate cox regression analysis. Higher LV mass and lower RV tricuspid annular plane systolic excursion were associated with increased odds of having ≥5% interstitial amyloid deposition on biopsy in the multivariate logistic regression analysis.ConclusionLower LA strain independently predicted mortality in our cohort, and its performance in the routine assessment of AL amyloidosis may be beneficial. Furthermore, SCT for cardiac AL amyloidosis was associated with improved OS. These findings need to be confirmed by larger studies in the era of contemporary systemic therapies.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1073804/fullcardiac AL amyloidosisechocardiographyhistomorphologypathologymortalityleft atrial strain (LA strain)
spellingShingle Efstratios Koutroumpakis
Adam Niku
Christopher K. Black
Abdelrahman Ali
Humaira Sadaf
Juhee Song
Nicolas Palaskas
Cezar Iliescu
Jean-Bernard Durand
Syed Wamique Yusuf
Hans C. Lee
L. Maximilian Buja
Anita Deswal
Jose Banchs
Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
Frontiers in Cardiovascular Medicine
cardiac AL amyloidosis
echocardiography
histomorphology
pathology
mortality
left atrial strain (LA strain)
title Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
title_full Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
title_fullStr Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
title_full_unstemmed Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
title_short Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
title_sort evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy proven cardiac al amyloidosis
topic cardiac AL amyloidosis
echocardiography
histomorphology
pathology
mortality
left atrial strain (LA strain)
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1073804/full
work_keys_str_mv AT efstratioskoutroumpakis evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT adamniku evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT christopherkblack evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT abdelrahmanali evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT humairasadaf evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT juheesong evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT nicolaspalaskas evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT cezariliescu evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT jeanbernarddurand evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT syedwamiqueyusuf evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT hansclee evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT lmaximilianbuja evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT anitadeswal evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis
AT josebanchs evaluationofcontemporaryechocardiographicandhistomorphologyparametersinpredictingmortalityinpatientswithendomyocardialbiopsyprovencardiacalamyloidosis